Search Results - "Thomas, Nadja"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Polyclonal Evolution of Multiple Secondary KIT Mutations in Gastrointestinal Stromal Tumors under Treatment with Imatinib Mesylate

    Polyclonal Evolution of Multiple Secondary KIT Mutations in Gastrointestinal Stromal Tumors under Treatment with Imatinib Mesylate by Wardelmann, Eva, Merkelbach-Bruse, Sabine, Pauls, Katharina, Thomas, Nadja, Schildhaus, Hans-Ulrich, Heinicke, Thomas, Speidel, Nicola, Pietsch, Torsten, Buettner, Reinhard, Pink, Daniel, Reichardt, Peter, Hohenberger, Peter

    Published in Clinical cancer research (15-03-2006)
    “…Gastrointestinal stromal tumors (GIST) are characterized by a strong KIT receptor activation most often resulting from KIT mutations. In a smaller subgroup of…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Regression of Glioma in Rat Models by Intranasal Application of Parvovirus H-1

    Regression of Glioma in Rat Models by Intranasal Application of Parvovirus H-1 by KIPRIANOVA, Irina, THOMAS, Nadja, AYACHE, Ali, FISCHER, Manuel, LEUCHS, Barbara, KLEIN, Michele, ROMMELAERE, Jean, SCHLEHOFER, Jörg R

    Published in Clinical cancer research (15-08-2011)
    “…In previous studies, we have shown that the apathogenic rat parvovirus H-1 (H-1PV) is capable to induce regression of advanced symptomatic rat and human…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models

    Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models by Geletneky, Karsten, Kiprianova, Irina, Ayache, Ali, Koch, Regina, Herrero y Calle, Marta, Deleu, Laurent, Sommer, Clemens, Thomas, Nadja, Rommelaere, Jean, Schlehofer, Jörg R.

    Published in Neuro-oncology (Charlottesville, Va.) (01-08-2010)
    “…Oncolytic virotherapy is a potential treatment modality under investigation for various malignancies including malignant brain tumors. Unlike some other…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutations

    Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutations by Wardelmann, Eva, Thomas, Nadja, Merkelbach-Bruse, Sabine, Pauls, Katharina, Speidel, Nicola, Büttner, Reinhard, Bihl, Heiner, Leutner, Claudia C, Heinicke, Thomas, Hohenberger, Peter

    Published in The lancet oncology (01-04-2005)
    Get more information
    Journal Article
    Save to List
    Saved in:
  5. 5
    Polyclonal Resistance in Gastrointestinal Stromal Tumor Treated with Sequential Kinase Inhibitors

    Polyclonal Resistance in Gastrointestinal Stromal Tumor Treated with Sequential Kinase Inhibitors by Wardelmann, Eva, Biermann, Katharina, Merkelbach-Bruse, Sabine, Schildhaus, Hans-Ulrich, Thomas, Nadja, Büttner, Reinhard, Pietsch, Torsten, Heinicke, Thomas, Speidel, Nicola, Pink, Daniel, Reichardt, Peter, Hohenberger, Peter

    Published in Clinical cancer research (15-10-2006)
    Get full text
    Journal Article
    Save to List
    Saved in:
  6. 6
    Polyclonal evolution of multiple secondary KIT mutations in gastrointestinal stromal tumors undertreatment with imatinib mesylate

    Polyclonal evolution of multiple secondary KIT mutations in gastrointestinal stromal tumors undertreatment with imatinib mesylate by WARDELMANN, Eva, MERKELBACH-BRUSE, Sabine, REICHARDT, Peter, HOHENBERGER, Peter, PAULS, Katharina, THOMAS, Nadja, SCHILDHAUS, Hans-Ulrich, HEINICKE, Thomas, SPEIDEL, Nicola, PIETSCH, Torsten, BUETTNER, Reinhard, PINK, Daniel

    Published in Clinical cancer research (2006)
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: